Buyang Huanwu Decoction promotes the neurological recovery of traumatic spinal cord injury via inhibiting apoptosis, inflammation, and oxidative stress

被引:2
|
作者
Li, Xu [1 ]
Song, Yingjun [1 ]
Yang, Yang [1 ]
Zhang, Guofu [1 ,2 ]
机构
[1] Univ Chinese Med, Dept Trauma Orthoped, Affiliated Hosp Jiangxi, Nanchang, Peoples R China
[2] Univ Chinese Med, Dept Trauma Orthoped, Affiliated Hosp Jiangxi, 445 Bayi Ave, Nanchang 330006, Peoples R China
基金
中国国家自然科学基金;
关键词
BYHWD; MSCs; spinal cord injury; STAT; traditional Chinese medicine; REGENERATION;
D O I
10.1002/iid3.933
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundThe incidence rate of spinal cord injury (SCI) is increasing, and the mortality or disability rate caused by SCI remains high in the world. Buyang Huanwu Decoction (BYHWD) is a kind of Traditional Chinese medicine, and it is believed to be effective in several kinds of nervous system diseases. Whether BYHWD could improve SCI and the potential function mechanism remain unclear. MethodsSCI animal model was established by damaging T10 spinal cord. Animals experiments included five groups as follows: Sham, SCI, SCI+BYHWD, SCI+mesenchymal stromal cells (MSCs), and SCI+BYHWD+MSCs. H2O2-treated cells (100 & mu;M, 6 h) were used to simulate SCI damage in vitro, which included five groups as follows: control, H2O2, H2O2+BYHWD, H2O2+MSCs, and H2O2+BYHWD+MSCs. The behavioral function was evaluated with Tarlov and inclined plated test score. Western blot analysis and immunohistochemical staining were used to detect protein expression. The levels of superoxide dismutase (SOD), catalase (CAT), malondiadehyde (MDA), interleukin (IL)-1 & beta;, tumor necrosis factor-& alpha;, and IL-6 in serum were measured with commercial enzyme-linked immunosorbent assay kits. terminal deoxynucleotidyl transferase dUTP nick end labeling staining and flow cytometry were performed to measure apoptosis in vivo and in vitro levels. Gene expression profiling analysis was performed to analyze differential expression genes. ResultsBYHWD suppressed apoptosis and accelerating cell proliferation after SCI. Recovery of neurofunction, inhibition of inflammatory response, and oxidative condition were achieved by BYHWD and MSCs. The expression levels of gp130/Janus kinase/signal transducers and activator of transcription (JAK/STAT) were suppressed by BYHWD and MSCs, both in vivo and in vitro. BYHWD and MSCs markedly promoted cells viability and inhibited apoptosis. Greater gene expression difference was observed between group control and H2O2 through gene expression profiling analysis. The recovery effects of traumatic SCI by BYHWD were similar to MSCs, and synergies effects were observed in several items. ConclusionBYHWD could increase Tarlov score and Basso, Beatie, and Bresnahan functional score, inhibit apoptosis, inflammatory response, and oxidative condition after SCI. The expression level of gp130/JAK/STAT axis was suppressed by BYHWD. BYHWD might be a new therapeutic strategy for the prevention or treatment of SCI.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Dexmedetomidine alleviates traumatic spinal cord injury in rats via inhibiting apoptosis induced by endoplasmic reticulum stress
    Liu, Yi-bin
    Liu, Wei-feng
    Chen, Wei-can
    Li, Wei
    Lin, Yan-ling
    Xu, Chong-jun
    He, He-fan
    NEUROLOGICAL RESEARCH, 2022, 44 (03) : 275 - 284
  • [22] Chloroquine Promotes the Recovery of Acute Spinal Cord Injury by Inhibiting Autophagy-Associated Inflammation and Endoplasmic Reticulum Stress
    Wu, Fenzan
    Wei, Xiaojie
    Wu, Yanqing
    Kong, Xiaoxia
    Hu, Aiping
    Tong, Songlin
    Liu, Yanlong
    Gong, Fanhua
    Xie, Ling
    Zhang, Jinjing
    Xiao, Jian
    Zhang, Hongyu
    JOURNAL OF NEUROTRAUMA, 2018, 35 (12) : 1329 - 1344
  • [23] MicroRNA-210 promotes spinal cord injury recovery by inhibiting inflammation via the JAK-STAT pathway
    Dai, J.
    Yu, G-Y
    Sun, H-L
    Zhu, G-T
    Han, G-D
    Jiang, H-T
    Tang, X-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (20) : 6609 - 6615
  • [24] Prussian Blue Nanozyme Treatment of Ischemic Brain Injury via Reducing Oxidative Stress Inhibits Inflammation, Suppresses Apoptosis, and Promotes Neurological Recovery
    Liu, Jian
    Sun, Jingyi
    Song, Yanan
    Wang, Mengyue
    Zhao, Peng
    Wang, Wendi
    Yang, Mingfeng
    Wang, Ying
    Song, Yuqiang
    Sun, Baoliang
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (08): : 1535 - 1546
  • [25] Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury
    Duan, Hui-Quan
    Wu, Qiu-Li
    Yao, Xue
    Fan, Bao-You
    Shi, Hong-Yu
    Zhao, Chen-Xi
    Zhang, Yan
    Li, Bo
    Sun, Chao
    Kong, Xiao-Hong
    Zhou, Xin-Fu
    Feng, Shi-Qing
    CNS NEUROSCIENCE & THERAPEUTICS, 2018, 24 (05) : 429 - 438
  • [26] MiR-7a ameliorates spinal cord injury by inhibiting neuronal apoptosis and oxidative stress
    Ding, L-Z
    Xu, J.
    Yuan, C.
    Teng, X.
    Wu, Q-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (01) : 11 - 17
  • [27] Cinepazide maleate promotes recovery from spinal cord injury by inhibiting inflammation and prolonging neuronal survival
    Li, Dadi
    Zhao, Shuxian
    Zhu, Bin
    Zhao, Wanmin
    Ding, Ya
    Li, Xuejun
    Fu, Donglin
    Yu, Haiyang
    Wang, Baogui
    Pan, Tan
    DRUG DEVELOPMENT RESEARCH, 2023, 84 (04) : 736 - 746
  • [28] Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway
    Zhang, Lilian
    Zhang, Weijiang
    Zheng, Binbin
    Tian, Naifeng
    NEUROCHEMICAL RESEARCH, 2019, 44 (04) : 763 - 775
  • [29] Sinomenine Attenuates Traumatic Spinal Cord Injury by Suppressing Oxidative Stress and Inflammation via Nrf2 Pathway
    Lilian Zhang
    Weijiang Zhang
    Binbin Zheng
    Naifeng Tian
    Neurochemical Research, 2019, 44 : 763 - 775
  • [30] Protective effect of Oxymatrine against acute spinal cord injury in rats via modulating oxidative stress, inflammation and apoptosis
    Guan, Binggang
    Chen, Rongchun
    Zhong, Mingliang
    Liu, Ning
    Chen, Qin
    METABOLIC BRAIN DISEASE, 2020, 35 (01) : 149 - 157